Christopher is Head of West Coast US Capital Markets and US Emerging Company/Venture Capital and Technology Sector Lead.

He represents public and private companies, investment banks and sponsors in corporate and finance matters, including debt and equity securities offerings, secured financings, mergers, acquisitions and strategic transactions, corporate governance and public company reporting and compliance. He regularly advises boards on strategic and governance matters and is viewed by CEO’s as a key business partner and trusted advisor.

In the area of securities offerings, Christopher has been involved in dozens of public and private securities offerings in the US and abroad, including initial public offerings, follow-on offerings, secondary offerings, confidentially marketed offerings, PIPEs, ATMs (at the market offerings), private offerings of seed and preferred stock and convertible and bridge note offerings. He represents issuers, underwriters and arrangers in these matters, and is well regarded for his creativity in structuring transactions and helping clients solve problems.

In the area of mergers, acquisitions and strategic transactions, Christopher has extensive experience representing strategic and financial buyers and sellers in transactional matters, including public and private company mergers, acquisitions and dispositions, carve-out and other asset transactions, and joint ventures. He has worked on transactions involving buyers and sellers in numerous transactions in North America, Europe, and Asia. Mr. Forrester has considerable expertise representing boards and other constituents in complex related party transactions.

In the area of corporate governance and public company reporting and compliance, Christopher represents public and private companies seeking to develop and maintain best practices in corporate governance. Mr. Forrester also regularly represents companies in their ongoing compliance with the Securities Exchange Act of 1934 and stock exchange requirements.


Representative matters

Public Securities Offerings and Related Transactions

 Citigroup, BofA Securities, Goldman Sachs & Co. LLC, and Mizuho as joint book-running managers and representatives of the underwriters in connection with Amgen’s registered $24 billion notes offering.

Cowen and Company, SVB Securities LLC and Evercore Group L.L.C in connection with Nkarta Inc.’s US$280 million initial public offering, its US$230 million follow-on public offering and the commencement of its at-the-market equity offering program to offer and sell common stock, having an aggregate offering price of up to US$150 million.

Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Barclays Capital Inc. and Morgan Stanley & Co. LLC with respect to multiple liability management transactions for Amgen, Inc. with a value in excess of $20 billion.

BofA Securities, Inc. and other underwriters in connection with FLIR System Inc.’s US$500 million note offering.

Cowen in connection with Adesto, Inc.’s sale of $75 million in convertible notes and in connection with its offering of $40 million of common stock.

Mubadala Development Co in connection with multiple sell-down transactions of Advanced Micro Devices stock from 2017 to 2019 with a value in excess of US$2 billion.

Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC with respect to multiple liability management transactions for eBay, Inc. with a value in excess of $5 billion.

Multi-Fineline Electronix, Inc. in its initial public offering.

BuildGroup in connection with US$80 million PIPEs in BenefitFocus (Nasdaq: BNFT) and in connection with the initial public offering of Build Acquisition Group.

Waha Capital in connection with US$50 million PIPEs in Despegar, Inc. (NYSE: DESP).

Multiple issuers and placement agents in connection with ATM transactions.
ContraFect Corporation in connection with its IPO as well as its US$20 million PIPE offering.

Arsenal Holdco I, S.a.r.l. and Arsenal Holdco II, S.a.r.l. (affiliates of Francisco Partners), Kanata Research Park Corporation and Shen Capital Corporation in connection with a secondary public offering of C$91 million of common stock of Mitel Networks Corporation (Nasdaq: MITL).

GXS Group, Inc. (a Francisco Partners portfolio company) in connection with demand and piggyback registration requests by OpenText Corporation, a total proposed maximum aggregate offering price of approximately US$124 million.

Robert W. Baird & Co. in connection with the underwritten offering of US$36 million of common stock of PowerSecure International, Inc. (Nasdaq: PWR).

First Albany in the initial public offering of Axesstel, Inc. (Nasdaq: AXST).

Idec Pharmaceuticals, Inc. in its US$657 million follow-on offering.

Idec Pharmaceuticals, Inc. in its US$1.2 billion offering of Liquid Yield Option Notes (LYONS).

Thomas Weisel Partners in its US$115 million follow-on offering of Arena Pharmaceuticals, Inc. (Nasdaq: ARNA).

M&A and Special Committee Engagements

Measurabl, Inc. in its acquisition of Hatch Data Inc.

Leyard Optoelectronic Co., Ltd. in connection with its US$156.8 million acquisition of Planar Systems, Inc. (Nasdaq: PLNR).

Tsinghua Unigroup Ltd., a subsidiary of Tsinghua University, in the following matters: US$1.8 billion acquisition of Shanghai-based fabless IC developer Spreadtrum Communications, Inc. (Nasdaq: SPRD); and US$910 million acquisition of China-based fabless semiconductor company RDA Microelectronics, Inc. (Nasdaq: RDA).

Far East Global Group Limited in connection with its HK$643 million acquisition by China State Construction International Holdings Limited via mandatory unconditional cash offer.

Xcel Pharmaceuticals, Inc. in its US$280 million sale to Valeant Pharmaceuticals, Inc.

MusicMatch, Inc. in its US$160 million sale to Yahoo!.

Idec Pharmaceuticals, Inc. (Nasdaq: IDEC) in its US$14 billion merger with Biogen, Inc. (Nasdaq: BGN).

Multi-Fineline Electronix, Inc. in connection with its proposed acquisition offer of Singapore-based MFS Technology Ltd., its acquisition of Applied Optics, Inc., its joint venture with Mobility, Inc. and its joint venture by and among Panoche Holdings, LLC and CED Panoche Valley holdings, LLC (ConEdison).

Private Offerings and Other Financing Matters

 Vice Media in connection with its $250 million secured debt financing with Soros Fund Management LLC, Fortress Investment Group LLC and Monroe Capital as well as various debt and equity financings led by Technology Crossover Ventures, TPG and other private equity investors.

Impossible Foods Inc. in connection with multiple financings.

Next Insurance in connection with its Series D, Series E and Series G financings.

Advantage Sales & Marketing Inc. on an amendment to its existing $400 million revolving credit facility facilitated by Bank of America to increase aggregate revolving commitments from $400 million to $500 million.

Aemetis, Inc. (Nasdaq: AMTX) in connection with its secured term loan and revolver with Third Eye Capital.

Renewable Energy Trust Capital, Inc. in connection with the following matters: its US$125 million stock financing; its project finance and development transactions with Origis I USA Inc. and Origis Holdings USA; its US$125 million Series C extension round; its US$21 million senior secured construction bridge loan to Panoche Valley Solar, LLC; and its joint venture by and among Panoche Holdings, LLC and CED Panoche Valley holdings, LLC (ConEdison).

ALJ Regional Holdings, Inc. in connection with its US$105 million senior term credit facility and US$30 million senior revolver facility.

City Light Capital in connection with a series of private placements in early stage companies.

Merrill Lynch (Asia Pacific) Limited as one of several lenders in a senior secured term loan to LDK New Energy Holding Limited, the parent company of LDK Solar Co., Ltd.

ALJ Regional Holdings, Inc. in its US$36 million debt and equity reorganization transaction.

Roth Capital Partners LLC in connection with Synthesis Energy Systems, Inc. investment by China Equity Dongxin.

ALJ Regional Holdings, Inc. in its US$27 million refinancing transaction.

Fuji Food Products, Inc. in its corporate restructuring and Series A preferred stock offering.

ALJ Regional Holdings, Inc. in its US$42 million corporate restructuring.

Xcel Pharmaceuticals, Inc. in connection with several rounds of private investment.

Published Work

  • Forrester, C. (2016) “Fiduciary Duties and Other Responsibilities of Corporate Directors and Officers”, R.R. Donnelley (Foreword by Professor John Buley Duke’s Fuqua School of Business), 6th Edition
  • Forrester, C. (2006) “Annual Review of Federal Securities Regulation,” The Business Lawyer
  • Forrester, C. (2005) “Annual Review of Federal Securities Regulation,” The Business Lawyer
  • Forrester, C. (2004) “Annual Review of Federal Securities Regulation,” The Business Lawyer

Speaking Engagements

  • Regularly speaks on securities and governance matters at Practicing Law Institute
  • Regularly speaks on securities and governance matters at Financial Executives International


  • Recommended lawyer, The Best Lawyers in America, 2016 
  • Recommended lawyer, The Best Lawyers in America for National, Corporate Law, Tier 1, 2014
  • Recommended lawyer, The Best Lawyers in America, 2013
  • 2013 Deal of the Year, China Business Law Journal
  • One of the best 10 business lawyers, San Diego’s The Daily Transcript
  • Top 40 Under 40 persons in the Finance Industry, Investment Dealers’ Digest, 2007
  • Leading lawyer in capital markets-equity Hong Kong, IFLR



California, 1996
District of Columbia, 1997
New York, 2021


B.A., St. Mary’s College, 1993
J.D., University of the Pacific, McGeorge School, 1996
LL.M., Securities Regulation, Georgetown University Law Center, 2002
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.